FDA provides update on its ongoing investigation into valsartan products

Washington, DC - The U.S. Food and Drug Administration is updating the public on the agency’s ongoing investigation surrounding the recent voluntary recall of several drug products containing the active pharmaceutical ingredient (API) valsartan, used to treat high blood pressure and heart failure.

FDA approves new kind of treatment for hairy cell leukemia

Washington, DC - The U.S. Food and Drug Administration approved Lumoxiti (moxetumomab pasudotox-tdfk) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog. Lumoxiti is a CD22-directed cytotoxin and is the first of this type of treatment for patients with HCL.

Suicide Prevention: Communication is Key

Atlantic Ocean - Throughout September Sailors aboard USS Harry S. Truman (CVN 75) will recognize Suicide Awareness and Prevention Month (SAPM) through a number of team-building activities. The goal of these events is to encourage positive communication as well as dispel possible misinformation about the Navy’s suicide awareness and prevention program.

Hundreds to Celebrate Their Recovery

San Diego, California - September is National Recovery Month, a time to increase awareness and understanding of mental and substance use disorders and celebrate the people who have overcome them.

SDSU Student Diagnosed with Meningococcal Disease

San Diego, California - An undergraduate student at San Diego State University has been diagnosed with an infection caused by the meningococcal bacteria and is being treated at a local hospital, the San Diego County Health and Human Services Agency reported Wednesday.